Unibest
← Back to patent-cliff list

CAS 2270865-22-8

1-[2-(Methylsulfanyl)pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde

Codes: (XV) 920279-3-a

Application context (from source-drug indications)

Non-small cell lung cancerLazertinib MesylateHepatic function declineLazertinib Mesylate

Source drugs (routes using this intermediate)

DrugTierExpiry
Lazertinib MesylateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Site3-phenyl-1H-pyrazole-4-carbaldehyde
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site4-Chloro-2-(methylsulfonyl)pyrimidine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works4-chloro-N-(2-methoxy-4-morpholino-5-nitrophenyl)pyrimidin-2-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site1-(2-((2-methoxy-4-morpholino-5-nitrophenyl)amino)pyrimidin-4-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-N-(2-methoxy-4-morpholino-5-nitrophenyl)pyrimidin-2-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API WorksN1-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)-6-methoxy-4-morpholinobenzene-1,3-diamine
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.